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IMPLICATIONS ANDPurpose: To evaluate the DSM-5 diagnosis of Avoidant/Restrictive Food Intake Disorder (ARFID) in
children and adolescents with poor eating not associated with body image concerns.
Methods: A retrospective case-control study of 8e18-year-olds, using a diagnostic algorithm,
compared all cases with ARFID presenting to seven adolescent-medicine eating disorder programs
in 2010 to a randomly selected sample with anorexia nervosa (AN) and bulimia nervosa (BN).
Demographic and clinical information were recorded.
Results: Of 712 individuals studied, 98 (13.8%) met ARFID criteria. Patients with ARFID were
younger than those with AN (n ¼ 98) or BN (n ¼ 66), (12.9 vs. 15.6 vs. 16.5 years), had longer
durations of illness (33.3 vs. 14.5 vs. 23.5 months), were more likely to be male (29% vs. 15% vs. 6%),
and had a percent median body weight intermediate between those with AN or BN (86.5 vs. 81.0
and 107.5). Patients with ARFID included those with selective (picky) eating since early childhood
(28.7%); generalized anxiety (21.4%); gastrointestinal symptoms (19.4%); a history of vomiting/
choking (13.2%); and food allergies (4.1%). Patients with ARFID were more likely to have a co-
morbid medical condition (55% vs. 10% vs. 11%) or anxiety disorder (58% vs. 35% vs. 33%) and were
less likely to have a mood disorder (19% vs. 31% vs. 58%).
Conclusions: Patients with ARFID were demographically and clinically distinct from those with AN
or BN. They were signiﬁcantly underweight with a longer duration of illness and had a greater
likelihood of comorbid medical and/or psychiatric symptoms.
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Table 1
DSM-5 diagnosis of Avoidant/Restrictive Food Intake Disorder [13]
A. An eating or feeding disturbance (e.g., apparent lack of interest in eating
or food; avoidance based on the sensory characteristics of food; concern
about aversive consequences of eating) as manifested by persistent fail-
ure to meet appropriate nutritional and/or energy needs associated with
one (or more) of the following:
1. Signiﬁcant weight loss (or failure to achieve expected weight gain or
faltering growth in children).
2. Signiﬁcant nutritional deﬁciency.
3. Dependence on enteral feeding or oral nutritional supplements.
4. Marked interference with psychosocial functioning.
B. The disturbance is not better explained by lack of available food or by
associated culturally sanctioned practice.
C. The eating disturbance does not occur exclusively during the course of
anorexia nervosa or bulimia nervosa, and there is no evidence of a
disturbance in the way in which one’s body weight or shape is
experienced.
D. Theeatingdisturbance isnot attributable toa concurrentmedical condition
or not better explained by another mental disorder. When the eating
disturbance occurs in the context of another condition or disorder, the
severity of the eating disturbance exceeds that routinely associated with
the condition or disorder and warrants additional clinical attention.
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with feeding or eating disorders cannot be classiﬁed using the
DSM-IV criteria [1e3]. Patients who did not meet the DSM-IV
criteria for anorexia nervosa (AN) or bulimia nervosa (BN) were
often given a diagnosis of eating disorder not otherwise speciﬁed
(EDNOS). Using the DSM-IV, over 50% of children and adolescents
with eating disorders were diagnosed with EDNOS [1]. Although
these patients did notmeet theDSM-IV criteria for a speciﬁc eating
disorder, they experienced clinical impairment in development
and function andwere at risk for severemedical complications [1].
EDNOS has been a heterogeneous category that includes a
subset of patients who are, in general, younger than those with
AN or BN and do not endorse signiﬁcant body image distortion or
a fear of weight gain [4e9]. Currently, there are no evidence-
based studies describing this group of patients. Anecdotally,
clinicians report that patients in this subset had experienced
choking episodes or vomiting followed by the development of
fear of eating solid foods, had restricted diets since early child-
hood, or had reported abdominal pain that had prevented them
from eating sufﬁciently. The Great Ormond Street criteria for
categorizing eating disorders in younger patients, including
functional dysphagia, selective eating, and food-avoidance
emotional disorder, were found to be more reliable, because
these diagnostic categories captured the presentations of many
of these children and adolescents [10].
The DSM-5 Eating Disorder Work Group was charged with
revising and updating the DSM-IV diagnostic criteria to provide
clinical guidelines for clinicians caring for individuals with eating
disorders, including such patients [11,12]. This meant improving
the deﬁnition of eating disorders in children and adolescents to
reﬂect the clinical expression of these disorders across the
developmental spectrum and lifespan. A speciﬁc goal of this work
groupwas to examine the variety of clinical presentations of those
patients who had been diagnosed with EDNOS, explore the clin-
ical utility of the DSM-IV category of Feeding Disorder of Infancy
or Early Childhood, and consider the variety of clinical pre-
sentations that did not ﬁt into the existing categories in the DSM-
IV (e.g., food-avoidance emotional disorder, selective eating). In
keeping with this goal, the work group revised the DSM-IV
diagnoses and combined the former sections “Eating Disorders”
and “Feeding and Eating Disorders of Infancy or Early Childhood”
into a single section, “Feeding and Eating Disorders,” with Avoi-
dant/Restrictive Food Intake Disorder (ARFID) as a newly
described diagnosis in this section (Table 1) [13]. It was anticipated
that the inclusion of ARFID as a diagnosis within Feeding and
Eating Disorders in the DSM-5 would improve clinical utility and
capture a population of young people who had an eating disorder,
experienced medical and psychological morbidities, and who
might otherwise be excluded from the DSM diagnostic criteria.
The purpose of this study was to describe the characteristics
of children and adolescents presenting to seven adolescent-
medicine eating disorder programs who met the DSM-5
criteria for ARFID and to compare them to patients meeting the
DSM-5 criteria for AN and BN. The same seven eating disorder
programs have recently published a paper demonstrating the
general distribution of eating disorder diagnoses in children and
adolescents using the DSM-5 criteria [14].
Methods
A retrospective chart review was completed on all new
patients between 8 and 18 years of age who presented to sevenadolescent-medicine eating disorder programs across the United
States and Canada between January and December 2010. Patients
with a diagnosis of ARFID were identiﬁed at each site using a
diagnostic checklist based on the proposed DSM-5 diagnostic
criteria. A table of random numbers was used to select an equal
number of patients with AN and BN. Cases of AN and BN were
identiﬁed based on DSM-5 criteria. At some sites, there were
fewer patients seen with BN than with ARFID. Under these cir-
cumstances, all patients with BN were enrolled, resulting in
fewer patients with BN than those with ARFID and AN.
Data collected on all patients included age, gender, ethnicity,
weight, and height. Additional clinical information included
duration of illness, highest and lowest weights and body mass
index (BMI) percentile, intake setting (out-patient vs. other),
referral source, and presence of a medical condition, mood dis-
order, anxiety disorder, autism spectrum disorder, cognitive
impairment, food allergies, a choking episode, difﬁculty swal-
lowing, or sensory issues.
The documented reason for poor nutritional intake in the
ARFID group was also delineated, and included selective (picky)
eating since early childhood, generalized anxiety, fear of vomit-
ing or choking, gastrointestinal symptoms, food allergies, and
“other” reasons.
Data were entered into EXCEL, and analyzed in aggregate by
one of the authors (B.T.W.). Chi-square analyses were used for
categorical variables and ANOVA for continuous variables. Post-
hoc testing was performed to assess statistical signiﬁcance be-
tween ARFID and AN groups and between ARFID and BN groups
when there was overall statistical signiﬁcance. For post-hoc
testing, Tukey’s Honestly Signiﬁcant Difference (HSD) was used
for continuous variables and 2-by-2 Chi-square analysis with
Bonferroni correctionwas used for categorical variables. Statistical
analysis was conducted using Stata 12.1 (StataCorp LP, College
Station, TX).
Institutional review boards/research ethics boards at each of
the participating study sites approved the study.
Results
A total of 712 new patients with eating disorders presented to
the seven study sites during 2010. Of these, 98 patients (13.8%)
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ARFIDwas fairly consistent across sites, with the exception of one
site (University of Michigan). At six of the seven sites, the fre-
quency of patients with ARFID ranged between 7.2% and 17.4%;
however, the incidence at the remaining site was 41.0%. The
number of patients who met DSM-5 criteria for AN and BN used
in the analysis to compare with the patients with ARFID were 98
and 66, respectively.
Characteristics of patients with ARFID, AN, and BN are sum-
marized in Table 2. Almost 30% of patients with ARFID were male,
a far higher percentage than those with either AN or BN. The
percent median body weight (% MBW) for patients with ARFID
(86.5) was between those with AN (81.0) and those with BN
(107.5). Patients with ARFID tended to be younger and had a
signiﬁcantly longer duration of illness. The majority of all patients
were evaluated as out-patients. Patients with ARFID were less
likely to be self-referred. Although patients with ARFIDweremore
likely to have a medical condition or an anxiety disorder than
thosewith ANor BN, theywere less likely to have amood disorder.
The authors grouped the ARFID patients according to speciﬁc
symptoms documented in the medical record. The groupings of
the ARFID patients included 28 (28.7%) with selective (picky)
eating since early childhood; 21 (21.4%) with generalized anxiety;
19 (19.4%) with gastrointestinal symptoms; 13 (13.1%) with fears
of eating secondary to fears of choking or vomiting; 4 (4.1%) with
food allergies; and 13 (13.2%) with restrictive eating for “other”
reasons. There were no statistically signiﬁcant differences by ageTable 2
Clinical characteristics of patients with ARFID, anorexia nervosa, or bulimia nervosa
ARFID (n ¼ 98) Anorexia nervosa (n ¼
Age (years) 12.9  2.5 15.6  1.9a
% Median body weight 86.5  15.1 81.0  9.2a
Lowest weight (kg) 35.0  11.9 41.4  7.3a
Highest weight (kg) 40.8  15.0 54.0  12.9a
Duration (months) 33.3  41.3 14.5  12.2a
Genderb,c
Female (%) 71.3 85.7
Male (%) 28.6 14.3
Intake setting
OPD (%) 87.7 85.7
Other (%) 12.3 14.3
Referral sourcec
Self (%) 6.2 10.2
PCP (%) 51.6 50.0
Mental health (%) 11.3 16.3
Emergency department (%) 10.3 11.2
Social service (%) 1.0 4.1
Other (%) 0 3.0
Medical condition or symptomb,c
Yes, related (%) 34.6 8.2
Yes, unrelated (%) 16.3 2.0
None (%) 49.1 89.8
Mood disorderc
MDD/dysthymia (%) 7.2 19.4
Other (%) 11.3 11.2
None (%) 81.5 69.4
Anxiety disorderb,c
GAD (%) 28.6 14.3
OCD (%) 6.1 8.2
Other (%) 23.5 13.3
None (%) 41.8 64.2
ARFID ¼ Avoidant/Restrictive Food Intake Disorder; GAD ¼ generalized anxiety diso
OPD ¼ out-patient department; PCP ¼ primary care physician.
a Signiﬁcant difference from ARFID, p  .05 by Tukey’s Honestly Signiﬁcant Differe
b Signiﬁcant difference between anorexia nervosa and ARFID by Chi-square, p < .05
c Signiﬁcant difference between bulimia nervosa and ARFID by Chi-square, p < .05or gender among the patients in these groups. Further, unlike the
patients with ARFID, patients with AN and BN had almost none of
the above associated symptoms.
Discussion
This is the ﬁrst study to describe a large cohort of children and
adolescents meeting the DSM-5 diagnostic criteria for ARFID.
Approximately 14% of all new eating disorder patients who
presented to seven adolescent-medicine eating disorders pro-
grams between January and December 2010 met these criteria.
The diagnostic criteria for ARFID are broad. Bryant-Waugh has
outlined a diagnostic checklist for criterion A of ARFID to facilitate
gathering the appropriate information [15]. Despite the novelty of
these criteria, clinicians who staffed programs focusing on eating
disorders were able to utilize information in the medical records
to make a diagnosis of ARFID in a substantial number of children
and adolescents.
This multicenter study revealed that all but one research site
had a similar incidence of patients with ARFID, suggesting that the
diagnosis of ARFID across sites was reliable and stable. The reasons
for the difference in the frequency of ARFID at the one site are
unclear. This site was known as a center that specialized in the
care of younger patients with eating disorders. Therefore, a higher
proportion of younger patients may have been directed to the site.
However, all datawere analyzed both including and excluding this
site and no differences in statistical analyses were found.98) Bulimia nervosa (n ¼ 66)
16.5  1.3a F[2,259] ¼ 71.2, p < .001
107.5 16a F[2,259] ¼ 80.8, p < .001
53.3  9.5a F[2,247] ¼ 64.7, p < .001
65.0  12.4a F[2,245] ¼ 59.1, p < .001
23.5  17.1 F[2,258] ¼ 11.3, p < .001
Chi-square (df ¼ 2) ¼ 15.0, p < .001
94.0
6.0
Chi-square (df ¼ 2) ¼ 5.6, p < .10
97.0
3.0
Chi-square (df ¼ 10) ¼ 26.7, p < .01
15.5
53.0
22.7
4.6
1.5
3.0
Chi-square (df ¼ 14) ¼ 54.4, < .001
4.6
6.1
89.3
Chi-square (df ¼ 4) ¼ 33.3, p < .001
23.1
35.4
41.5
Chi-square (df ¼ 6) ¼ 23.4, p < .001
7.6
1.5
24.2
66.7
rder; MDD ¼ major depressive disorder; OCD ¼ obsessive-compulsive disorder;
nce (HSD).
after Bonferroni correction.
after Bonferroni correction.
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with ARFID were signiﬁcantly different clinically from those with
AN or BN. Although ARFID is a broad category that captures a
range of clinical presentations, children and adolescents with
this diagnosis were younger, had a longer duration of illness prior
to diagnosis, and included a greater number of males than
patients with AN or BN. In addition, although the % MBW for
patients with ARFID was between those with AN and BN, the
overall % MBWwas still low. Clinicians should recognize that low
% MBW may be a sign of an eating disorder. Further, clinicians
should also be aware that weight loss and low % MBW may not
only occur in patients with AN, but can also occur in children and
adolescents with ARFID. Therefore, children and adolescents
with ARFID should be assessed in a similar way as patients with
AN because they are at risk for the same medical complications.
Patients with ARFID were more likely to have a medical
condition or symptom compared with patients with AN or BN.
Further, patients with ARFID were signiﬁcantly more likely to
have an anxiety disorder than patients with AN or BN, but less
likely to have depression.
A large number of children and adolescents included in this
group had an eating or feeding disturbance that was manifested
by persistent failure to meet appropriate nutritional and/or en-
ergy needs and experienced signiﬁcant associated physiological
or psychosocial problems. Some data suggest that other disor-
ders, such as anxiety disorders, obsessive-compulsive disorders,
attention deﬁcit disorders, and autism spectrum disorders, may
be associated with ARFID [4]. Although we identiﬁed children
and adolescents with psychological disorders, wewere unable to
determine whether these should be considered risk factors for
the development of ARFID. Many of the patients experienced
generalized anxiety and gastrointestinal symptoms. Importantly,
a diagnosis of ARFID was given only when the feeding distur-
bance itself caused signiﬁcant clinical impairment that required
intervention beyond what is usually required for the other
condition.
As this was a retrospective chart review, the course of the
illness for these individuals is unknown. It is possible that these
children and adolescents with ARFID could develop another
eating disorder such as AN or BN. Further, it has been postulated
that children and adolescents with ARFID may be at risk of
impaired social functioning and family functioning, especially if
there is great stress surrounding mealtimes. Further prospective
and long-term follow-up studies are required.
This study has several limitations. This was a cross-sectional
retrospective chart review and relied on information that was
available in existing medical records. In addition, there was no
examination of the reliability of diagnostic assessment. However,
in a ﬁeld trial sponsored by the American Psychiatric Association
prior to the publication of DSM-5, ARFID was found to have good
reliability [16]. Finally, this study was performed in adolescent
medicine tertiary care centers. For these reasons, care should be
taken in generalizing results from this sample.
This is the ﬁrst multicenter study to support the identiﬁca-
tion of ARFID as a separate diagnostic group with unique clinicalcharacteristics. Children and adolescents with ARFID were both
demographically and clinically distinct from those with AN and
BN. ARFID captures a subset of patients who have distinct clinical
features who were either included among the heterogeneous
group of EDNOS in DSM-IV or not recognized as having an eating
disorder. Increasing recognition of children and adolescents with
ARFID should occur with the clear articulation of the diagnostic
criteria for this disorder outlined in the DSM-5. This will allow
earlier access to care, with prompt identiﬁcation and treatment
of medical and psychiatric complications. The clinical utility of
this unique diagnostic category and its relative prognostic and
therapeutic implications are not known and require investiga-
tion. Nonetheless, recognition of ARFID in the DSM-5 will stim-
ulate further research into its characteristics, and provide needed
information on course, prognosis, and treatment approaches.
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